ADVERTISEMENT

Motilal Oswal: Pharma Sector Outlook

The Nifty Pharma index is on the verge of a fresh breakout and surpassing its falling supply trend line on lower time frame.

Finished tablets cascade down the channels of a packaging machine during the manufacture of the Favipiravir antiviral medicine at a plant in Khimki, Russia. (Photographer: Andrey Rudakov/Bloomberg)
Finished tablets cascade down the channels of a packaging machine during the manufacture of the Favipiravir antiviral medicine at a plant in Khimki, Russia. (Photographer: Andrey Rudakov/Bloomberg)
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More